Abiopharma

🔍 Grossman Jerrold B (Executive)

Company: ADMA BIOLOGICS, INC. (ADMA)

Report Date: 2025-06-09

Detailed Transactions and Holdings:

• Acquired 10,000 shares of Common Stock at $5.0 per share (Direct)
  Date: 2025-06-09 | Code: M | equity_swap_involved: 0 | shares_owned_after: 488,194.00 | transaction_form_type: 4
• Sold 10,000 shares of Common Stock at $21.31 per share (Direct)
  Date: 2025-06-09 | Code: S | equity_swap_involved: 0 | shares_owned_after: 478,194.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-06-09 | Code: H | nature_of_ownership: See footnote | shares_owned_after: 22,857.00 | Footnotes: F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-06-09 | Code: H | nature_of_ownership: See footnote | shares_owned_after: 31,381.00 | Footnotes: F4
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-06-09 | Code: H | nature_of_ownership: See footnote | shares_owned_after: 38,294.00 | Footnotes: F5
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-06-09 | Code: H | nature_of_ownership: See footnote | shares_owned_after: 175.00 | Footnotes: F6
• Sold 10,000 shares of Stock Option (right to buy) at $5.0 per share (Derivative)
  Date: 2025-06-09 | Code: M | Expires: 2027-02-14 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F7

Footnotes:

• F1: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.29 to $21.35. The reporting person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
• F2: Includes, as of the transaction date, (i) 10,889 restricted stock units granted on February 19, 2025, which will vest in full on February 19, 2026, subject to the Reporting Person's continued service as of the applicable vesting date; and (ii) 467,305 shares of common stock owned by the reporting person.
• F3: These shares are owned by Brookwood LLC ("Brookwood"). The reporting person is the managing member of Brookwood.
• F4: These shares are owned by the Jerrold Grossman 2019 Irrevocable Trust, of which Dr. Grossman serves as investment trustee.
• F5: These shares are owned by Genesis Foundation Inc. ("Genesis"). The reporting person is the President of Genesis.
• F6: These shares are owned by the reporting person's wife.
• F7: These options were granted on February 14, 2017 and vested in twenty-four equal monthly installments, becoming fully vested on February 14, 2019.